Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma

Canadian Journal of Surgery

Volumn 54, Issue 2, 2011, Pages 89-94

  Shen, Shun Li ^a   Liang, Li Jian ^a   Peng, Bao Gang ^a   He, Qiang ^a   Kuang, Ming ^a   Lai, Jia Ming ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953245124     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.028009     Document Type: Article

References (16)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-76. (Pubitemid 46890874)
2. Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 2006;12:7561-7. (Pubitemid 46040565)
3. Li Q, Xu B, Fu L, et al. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma. J Exp Clin Cancer Res 2006;25:403-9. (Pubitemid 44763732)
4. Zhou J, Tang ZY, Fan J, et al. The potential of plasma thrombo - modu lin as a biomarker of portal vein tumor thrombus in hepato - cellular carcinoma. J Cancer Res Clin Oncol 2001;127:559-64. (Pubitemid 32757490)
5. Kim HK, Lee KR, Yang JH, et al. Plasma levels of D-dimer and soluble fibrin polymer in patients with hepatocellular carcinoma: a possible predictor of tumor thrombosis. Thromb Res 2003;109:125-9. (Pubitemid 36428763)
6. Guo WX, Man XB, Yuan HX, et al. [Proteomic analysis on portal vein tumor thrombus-associated proteins for hepatocellular carcin - oma] [Article in Chinese]. Zhonghua Yi Xue Za Zhi 2007;87:2094-7.
7. Ohnishi K, Sato S, Tsunoda T, et al. Portal venous hemodynamics in hepatocellular carcinoma. Effects of hepatic artery embolization. Gastroenterology 1987;93:591-6. (Pubitemid 17130854)
8. Wada Y, Nakashima O, Kutami R, et al. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 1998;27:407-14. (Pubitemid 28081054)
9. Unitt E, Rushbrook SM, Marshall A, et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005;41:722-30. (Pubitemid 40462933)
10. Gao Q, Qiu SJ, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcin - oma after resection. J Clin Oncol 2007;25:2586-93. (Pubitemid 47041232)
11. Fu J, Xu D, Liu Z, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcin - oma patients. Gastroenterology 2007;132:2328-39. (Pubitemid 46890865)
12. Piersma SJ, Jordanova ES, van Poelgeest MI, et al. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res 2007;67:354-61. (Pubitemid 46142795)
13. van Beek J, zur Hausen A, Snel SN, et al. Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases. Am J Surg Pathol 2006;30:59-65. (Pubitemid 43740210)
14. Shimizu H, Ito H, Kimura F, et al. Decreased cell-mediated immune status in colorectal cancer patients with hepatic metastasis. Hepatogastro enterology 2005;52:1106-9. (Pubitemid 40942195)
15. Ghiringhelli F, Menard C, Puig PE, et al. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother 2007;56:641-8. (Pubitemid 46348738)
16. Liang LJ, Hu WJ, Yin XY, et al. Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy. World J Surg 2008;32:627-31.